News
20h
News-Medical.Net on MSNSemaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial showsA phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
A Wild West weekend at Texas Motor Speedway for the three NASCAR national series ended with three overtime finishes. From the ...
Animal rescuers were desperately seeking assistance Monday after nearly 70 cats, including newborn kittens, were found in a ...
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...
19h
mlive on MSNDetroit Tigers mash 13 runs to cap series win in AnaheimThe Tigers (22-13) took three of four from the Angels and head into Monday’s off-day with the AL's best record.
The Laval Rocket returned to a packed Place Bell looking to apply the broom to the Cleveland Monsters in the North Division ...
Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...
38m
Space on MSNHubble Space Telescope View Of Barred Spiral Galaxy UGC 678The Hubble Space Telescope captures stunning imagery of barred spiral galaxy UGC 678. The galaxy is located about 260 million light-years away from Earth in the Pisces constellation. Credit: Space.com ...
SamsCooking on MSN15h
Sausage and Mash Pie RecipeMiní, a wild-born female jaguar, takes an unbelievable journey from the Iberá Wetlands to the Gran Chaco forest to revive a ...
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.
How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results